BRPI0713377A2 - formulação nutritiva, e, uso de uma formulação - Google Patents

formulação nutritiva, e, uso de uma formulação Download PDF

Info

Publication number
BRPI0713377A2
BRPI0713377A2 BRPI0713377-4A BRPI0713377A BRPI0713377A2 BR PI0713377 A2 BRPI0713377 A2 BR PI0713377A2 BR PI0713377 A BRPI0713377 A BR PI0713377A BR PI0713377 A2 BRPI0713377 A2 BR PI0713377A2
Authority
BR
Brazil
Prior art keywords
source
lipid
fatty acids
weight
formulation
Prior art date
Application number
BRPI0713377-4A
Other languages
English (en)
Inventor
Elizabeth Langford Jane
Sullivan Ian
Teresa Deering Catherine
Helen Giffen Sandra
Original Assignee
Shs International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shs International Ltd filed Critical Shs International Ltd
Publication of BRPI0713377A2 publication Critical patent/BRPI0713377A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULAçãO NUTRITIVA, E, USO DE UMA FORMULAçãO. Uma formulação nutritiva para o tratamento de condições inflamatórias do trato gastrintestinal (especialmente da doença de Crohn em pacientes pediátricos) que é composta de: (a) uma fonte de lipídio, (b) uma fonte de carboidratos, e (c) uma fonte de proteínas, onde a fonte de lipídio é composta de uma relação em peso de ácidos graxos n-6:n-3 de 1:3, pelo menos 90% em peso dos ácidos graxos n-3 na fonte de lipídio são fornecidos por ácido alfa-linolênico e pelo menos 90% em peso dos ácidos graxos n-6 na fonte de lipídio são fornecidos por ácido linoleico, e os componentes (a), (b) e (c) em conjunto fornecem pelo menos 400 kcal de energia por 100 g de peso total de (a)-(c).
BRPI0713377-4A 2006-06-27 2007-06-27 formulação nutritiva, e, uso de uma formulação BRPI0713377A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0612671.8A GB0612671D0 (en) 2006-06-27 2006-06-27 Nutritional formulation
GB0612671.8 2006-06-27
PCT/GB2007/002406 WO2008001086A1 (en) 2006-06-27 2007-06-27 Nutritional formulation

Publications (1)

Publication Number Publication Date
BRPI0713377A2 true BRPI0713377A2 (pt) 2012-03-13

Family

ID=36888109

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713377-4A BRPI0713377A2 (pt) 2006-06-27 2007-06-27 formulação nutritiva, e, uso de uma formulação

Country Status (6)

Country Link
US (1) US20090238893A1 (pt)
EP (1) EP2034854A1 (pt)
CN (1) CN101478891A (pt)
BR (1) BRPI0713377A2 (pt)
GB (1) GB0612671D0 (pt)
WO (1) WO2008001086A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111903962A (zh) * 2020-05-25 2020-11-10 上海复旦奥医医学科技有限公司 一种胃溃疡和十二指肠溃疡专用型临床营养配方及其制备

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374452B1 (en) * 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nutrient composition
US10576110B2 (en) * 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
US8840950B2 (en) * 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
MX350541B (es) * 2010-09-24 2017-09-08 Univ Florida Materiales y metodos para mejorar la funcion gastrointestinal.
KR20130140715A (ko) * 2010-10-14 2013-12-24 아샤 누트리션 사이언시스, 인코퍼레이티드 최적화된 영양 조제물, 그것으로부터의 맞춤 식이의 선택 방법 및 그것의 사용 방법
CN103384478B (zh) 2010-12-29 2016-11-23 雅培制药有限公司 降低婴儿、幼儿或儿童的坏死性小肠结肠炎、腹痛和短肠综合征的发病率的方法
CN103347403B (zh) 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法
FI124323B (fi) * 2011-02-18 2014-06-30 Valio Oy Maitopohjainen tuote ja menetelmä sen valmistamiseksi
US8765201B2 (en) * 2011-06-08 2014-07-01 Creneau Creations, Inc. High calorie food product and method
US20130052284A1 (en) * 2011-08-29 2013-02-28 Carolyn J. Harrington Palm kernel oil-based intranasal composition and use
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2014138304A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc., Rice protein supplements
EP2968241B1 (en) 2013-03-11 2018-10-31 University of Florida Research Foundation, Inc. Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
CN103431276A (zh) * 2013-08-31 2013-12-11 山东卫康生物医药科技有限公司 一种供炎性肠病患者食用的五谷杂粮全营养配方食品
CN103621871B (zh) * 2013-11-27 2015-04-29 山东隆科特酶制剂有限公司 一种复合氨基酸保健品及其制备方法
WO2015085351A1 (en) * 2013-12-12 2015-06-18 Newsouth Innovations Pty Limited Pharmaconutrient composition
CN104026591A (zh) * 2014-04-04 2014-09-10 上海英莱腾医药研究有限公司 一种含中链甘油三酯的多功能蛋白食品组合物
JP6959136B2 (ja) * 2015-01-23 2021-11-02 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 患者の示差的な栄養所要量の決定方法
HK1245658A1 (zh) * 2015-01-23 2018-08-31 Société des Produits Nestlé S.A. 可用於治疗ibd患者的营养组合物
AU2016208459A1 (en) * 2015-01-23 2017-06-15 Société des Produits Nestlé S.A. Promotion of healing of intestinal mucosa using proline, serine and threonine
CN105685973B (zh) * 2016-02-04 2018-08-24 中山大学附属第六医院 一种肠内营养剂
CN106723086A (zh) * 2016-11-16 2017-05-31 邓先觉 一种适用于儿童的医用肠内营养膳食及其配制方法
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION
CN107969701A (zh) * 2017-11-27 2018-05-01 北京特食生物科技研究中心（有限合伙） 一种适用于低能耗生产医用食品的高稳定性营养油脂原料
CZ2018242A3 (cs) * 2018-05-25 2020-01-15 Euro Enterprise Development s.r.o. Nutriční kompozice
CN109527123A (zh) * 2018-12-14 2019-03-29 大连大学 一种对慢性肠炎具有改善作用的调和油
CN110916088A (zh) * 2019-11-04 2020-03-27 齐鲁工业大学 一种适合炎性肠病人群的全营养特医食品及制备方法
CN110638043A (zh) * 2019-11-04 2020-01-03 光明乳业股份有限公司 一种富含益生菌的全营养配方食品及其制备方法与应用
CN110638042A (zh) * 2019-11-04 2020-01-03 光明乳业股份有限公司 一种全营养配方食品及其应用
CN115697084A (zh) * 2020-04-01 2023-02-03 沃尔夫森医疗中心 溃疡性结肠炎膳食、配方、产品及其方法
CN113679038B (zh) * 2021-08-31 2023-10-13 西安交通大学医学院第一附属医院 一种适用于克罗恩病的全营养膳食组合物及其制备方法
CN118304311A (zh) * 2024-03-31 2024-07-09 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） 一种能够有效治疗克罗恩病的新型氨基酸型肠内营养制剂配方

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0848626A (ja) * 1994-08-08 1996-02-20 Morishita Roussel Kk 脂肪輸液剤
JP4394174B2 (ja) * 1995-09-06 2010-01-06 イーエヌ大塚製薬株式会社 炎症性腸疾患治療剤
EP0852913A1 (en) * 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
JP5473190B2 (ja) * 2003-10-16 2014-04-16 ネステク ソシエテ アノニム 化学療法又は放射線療法の副作用に対する栄養組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111903962A (zh) * 2020-05-25 2020-11-10 上海复旦奥医医学科技有限公司 一种胃溃疡和十二指肠溃疡专用型临床营养配方及其制备

Also Published As

Publication number Publication date
CN101478891A (zh) 2009-07-08
EP2034854A1 (en) 2009-03-18
GB0612671D0 (en) 2006-08-09
WO2008001086A1 (en) 2008-01-03
US20090238893A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
BRPI0713377A2 (pt) formulação nutritiva, e, uso de uma formulação
BR112014019927A8 (pt) fórmula nutricional, método de preparação da referida fórmula antes da sua ingestão por um indivíduo, uso da referida fórmula, dispositivo para prepará-la e recipiente
Chin et al. Therapeutic effects of olive and its derivatives on osteoarthritis: From bench to bedside
DK2073647T3 (da) Ketogen diæt
Guerendiain et al. Changes in plasma fatty acid composition are associated with improvements in obesity and related metabolic disorders: a therapeutic approach to overweight adolescents
GB2459809A (en) Fatty acid formulations and methods of use thereof
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
BRPI1009860A8 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
ITMI20020269A0 (it) Uso di steri etilici di acidi poliinsaturi omega-3 in pazienti con insufficienza cardiaca
BR112013024189A2 (pt) métodos para aprimorar saúde óssea em crianças com o uso de ácidos graxos poli-insaturados de cadeia longa
HRP20120261T1 (hr) Postupak za smanjenje udjela zasićenih masnih kiselina u mliječnoj masti, dobivanje proizvoda i njihova primjena
BR112018000242A2 (pt) composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico
BR112015032572A2 (pt) composições e métodos para melhorar o desempenho durante exercícios
BRPI0512528A (pt) uso de ácidos graxos poliinsaturados, composição nutricional, e, uso de uma composição
Pizzorno Bariatric surgery: bad to the bone, part 1
BRPI0921917B8 (pt) formulação farmacêutica.
EP2032526A4 (en) UNSATURATED ALKYL ESTERS FROM 5-AMINOLEVULINIC ACID AND THEIR PREPARATION AND USE
BR112017027909A2 (pt) composição, e, uso de uma composição
Bai et al. Myricetin and quercetin are naturally occurring co-substrates of cyclooxygenases in vivo
Pita et al. Plasma urea-cycle-related amino acids, ammonium levels, and urinary orotic acid excretion in short-bowel patients managed with an oral diet
ES2579828T3 (es) Composición para la prevención y el tratamiento de la artritis reumatoide
DK1904044T3 (da) Anvendelse af en kombination omfattende L-carnitin, eller alkanoyl-L-carnitin, en fedtopløselig benzoquinon og en omega-3 polyumættet fedtsyre til fremstilling af et kosttilskud, eller et medikament, til behandling af hornhindesygdomme
BR112016012233A8 (pt) composições compreendendo cinamaldeído, e seus usos
Coelho et al. Chronic fish oil supplementation partially reverses renal alterations in mice fed with a high-fat diet

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2230 DE 01/10/2013.

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/12 (2016.01), A23L 33/115 (2016.01), A23L